Biotech Healthcare proudly introduced its newest advancement in intraocular lens technology — Optiflex XTENSE Comfort Plus, a Full Visual Range EDOF IOL, during the ESCRS 2025 meeting in Copenhagen. The product launch at Biotech’s booth drew widespread attention and appreciation...
The exhibition ‘Windows of the Soul’, part of the Bloomsbury Festival in London, has been pioneered by a combination of young scientists, clinicians and artists, some of whom are visually impaired themselves.
A new study by a team from Moorfields Eye Hospital and Guy’s and St Thomas’ will examine the role of mindfulness in potentially helping people who have visual snow syndrome.
Glasgow-based poet Nuala Watt (39) aims to show that disabled people “have important things to say” in her latest book of poems, ‘The Department of Work and Pensions Assesses a Jade Fish’.
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
A new study has identified a major genetic contributor to Fuchs’ Endothelial Corneal Dystrophy (FECD), a common cause of vision loss, also highlighting the significant roles of sex and ancestry. FECD is a common, inherited eye condition that primarily affects...
@12:45 – 13:45
Join Masara Laginaf, Consultant Ophthalmologist and Purvi Thomson, Lead Optometrist at OCL Vision, for an exploration of premium lens technologies available for your patients. Enhance your expertise in fine-tuning visual outcomes and explore the importance of tear film treatment.
The purpose of this study was to investigate the frequency and type of visual symptoms following stroke and evaluate what certain factors were associated with the absence of visual symptoms. This was a prospective, multi-centre, observation cohort study with 915...
The authors present six cases of visual loss in patients treated with ethambutol for mycobacterium avium complex, including four patients with bitemporal hemianopsia. Two additional patients were undergoing glaucoma monitoring and developed visual field defects with ethambutol treatment, which recovered...